What are the expected serum cortisol levels after overnight dexamethasone (Decadron, generic name: dexamethasone) suppression testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

In the context of overnight dexamethasone testing, a serum cortisol level of less than 1.8 μg/dL (50 nmol/L) the morning after taking 1 mg of dexamethasone is considered a normal response, indicating proper functioning of the hypothalamic-pituitary-adrenal axis. This threshold is based on the most recent guideline update from 2021, as outlined in the consensus on diagnosis and management of Cushing's disease published in The Lancet Diabetes and Endocrinology 1. The overnight dexamethasone suppression test is a crucial diagnostic tool for assessing cortisol regulation, with values above the 1.8 μg/dL threshold suggesting abnormal cortisol regulation and potentially indicating conditions like Cushing's syndrome.

Key points to consider in interpreting the results of the overnight dexamethasone suppression test include:

  • A serum cortisol level of less than 1.8 μg/dL (50 nmol/L) is considered a normal response, strongly predicting the absence of Cushing's syndrome (CS) 1.
  • Higher cutoff points, such as 5 μg/dL (138 nmol/L), reduce the sensitivity of the test 1.
  • False-positive results can occur due to factors such as rapid absorption or malabsorption of dexamethasone, concomitant treatment with CYP3A4 inducers, and increased corticosteroid binding globulin (CBG) levels 1.
  • Measuring dexamethasone concomitantly with cortisol and using laboratory-specific ranges can help reduce the risk of false-positive results 1.
  • False-negative results are less common but can be caused by inhibition of dexamethasone metabolism by certain medications or decreased CBG and albumin levels 1.

In clinical practice, it is essential to consider these factors and interpret the results of the overnight dexamethasone suppression test in the context of the individual patient's clinical presentation and medical history, as outlined in the guideline update 1.

From the Research

Expected Serum Cortisol Results for Overnight Dexamethasone Testing

  • The normal value after dexamethasone suppression is less than 2 micrograms/dL, rather than less than 5 micrograms/dL as has generally been accepted 2.
  • Using a cut-off for a morning cortisol following overnight dexamethasone of > 5 microg/dL, only three of 17 patients failed to suppress to a value less than this cut-off (sensitivity 18 %) 3.
  • A cut-off of > 2 microg/dL gave similar sensitivity, and even with a stringent cut-off point of > 1.8 microg/dL, only seven of 17 patients failed to suppress to a value less than this cut-off point (sensitivity of 41 %) 3.
  • Cortisol after 1-mg DST confirmed high sensitivity (100% at 50 nmol/L cut-off) and moderate-low specificity (63%, increased to 91% at 138 nmol/L) to diagnose Cushing's syndrome in the whole cohort of patients 4.
  • The use of 5 micrograms/dL as the normal value may lead to an unnecessary delay in diagnosis, as some individuals with Cushing's syndrome partially suppress their cortisol levels to less than 5 but more than 2 micrograms/dL during the test procedure 2.

Dexamethasone and Cortisol Concentrations

  • Plasma dexamethasone was associated with plasma cortisol (P<0.001), and the regression line suggested a strong negative association related to dexamethasone levels <5 nmol/l 5.
  • However, among the 94% of subjects with plasma dexamethasone >5.0 nmol/l, there was no association between dexamethasone and cortisol levels (P=0.55) 5.
  • Dexamethasone measurements may identify subjects with inadequately low plasma dexamethasone and may therefore be of value when retesting subjects with possibly false-positive DST results 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.